low glutathione and lung cancer

low glutathione and lung cancer Distinct roles for the thioredoxin antioxidant systems in Nrf2-Mediated tumor initiation and progression Glutathione Depletion and Stalwart Anticancer – Endogenous antioxidants in the prognosis

Name: low glutathione and lung cancer Distinct roles for the thioredoxin antioxidant systems in Nrf2-Mediated tumor initiation and progression Glutathione Depletion and Stalwart Anticancer – Endogenous antioxidants in the prognosis
Brand: lcog.de
SKU: 11360524247
Price: 21.43 USD
Availability: InStock
Rating: 4.5193 (9 reviews)

Endogenous antioxidants in the prognosis and treatment of lung cancer ScienceDirect Utilizing glutathione triggered nanoparticles to enhance chemotherapy of lung cancer by reprograming the tumor microenvironment ScienceDirect Frontiers Glutathione responsive and exhausting metal nanomedicines for robust synergistic cancer therapy Frontiers A prognostic signature of Glutathione metabolism associated long non coding RNAs for lung adenocarcinoma with immune microenvironment insights Role of the Glutathione Metabolic Pathway in Lung Cancer Treatment and Prognosis: A Review Journal of Clinical Oncology

SKU: 11360524247 · From lcog.de

4.5

USD21.43 USD64.43

Pay in 4 interest-free payments of $5.36 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

[DOI] [PMC free article] [PubMed] [Google Scholar] 567.Hooper DC, Spitsin S, Kean RB, Champion JM, Dickson GM, Chaudhry I, Koprowski H

Nat Rev Immunol 7:161167 Piletz J, Halaris A, Iqbal O, Hoppensteadt D, Fareed J, Zhu H, Sinacore J, DeVane C (2009) Pro-inflammatory biomakers in depression: treatment with venlafaxine